China vs Serbia: Death rate from Alzheimer's
China
35.74 deaths per 100,000 people
in 2021
Serbia
37.12 deaths per 100,000 people
in 2021
China rank
37th
Serbia rank
35th
Death rate from Alzheimer's over time
- China
- Serbia
How they compare
Serbia currently reports 37.12 deaths per 100,000 people against 35.74 deaths per 100,000 people in China, a difference of 1.38 deaths per 100,000 people.
The two have swapped places 1 time across 22 shared years of data; in 2000 it was China ahead.
China ranks 37th and Serbia ranks 35th of 194 countries.
Across the 3 decades both report, China averaged higher in 2 and Serbia in 1.
Head to head by decade
| Decade | China | Serbia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 17.89 deaths per 100,000 people | 4.14 deaths per 100,000 people | 13.75 deaths per 100,000 people | China |
| 2010s | 26.3 deaths per 100,000 people | 22.92 deaths per 100,000 people | 3.38 deaths per 100,000 people | China |
| 2020s | 33.63 deaths per 100,000 people | 36.64 deaths per 100,000 people | 3.01 deaths per 100,000 people | Serbia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher death rate from alzheimer's, China or Serbia?
- Serbia, at 37.12 deaths per 100,000 people against 35.74 deaths per 100,000 people in China as of 2021.
- What is the difference in death rate from alzheimer's between China and Serbia?
- 1.38 deaths per 100,000 people, with Serbia ahead.
- How many years of comparable data are there for China and Serbia?
- 22 years are reported by both, from 2000 to 2021.
- How do China and Serbia rank globally for death rate from alzheimer's?
- China ranks 37th and Serbia ranks 35th of 194 countries.
- Where does this data come from?
- World Health Organization (2024) – with major processing by Our World in Data, published as Death rate from Alzheimer's. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Estimated number of deaths from alzheimer disease and other dementias in both sexes, per 100,000 people.